Company / Profit Margin
Dianthus Therapeutics, Inc. /DE/ Profit Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-7973.3%
FY2025
5-year range
-7973.3% / -1541.2%
FY2024-FY2025
Trend
-417.3%
vs FY2024
Sector context
#142 of 145
Health Care
What the data says
Among 145 Health Care companies, Dianthus Therapeutics, Inc. /DE/ is in the bottom 2% for profit margin.
Based on SEC 10-K filings.
-7973.3% in FY2025.
Health Care sector context is included.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 145This company -7973.3% Sector average -792.7%
▼
-905.9% below sector average
Key checks
Key Insights
- In FY2025, profit margin decreased 417.3% year-over-year.
- Currently 7180.6pp below the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 4.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -7973.3% | -417.3% |
| FY2024 | -1541.2% | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026